The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.

Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study / Bartoletti, M., Giannella, M., Lewis, R.E., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Cerenzia, M.T., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - (2019), pp. 1-9. [10.1093/cid/ciz032]

Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study

Merli, Manuela
Writing – Original Draft Preparation
;
Baldassarre, Maurizio;
2019

Abstract

The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.
2019
beta-lattamici, antibiotic therapy, liver cirrhosis
01 Pubblicazione su rivista::01a Articolo in rivista
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study / Bartoletti, M., Giannella, M., Lewis, R.E., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Cerenzia, M.T., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - (2019), pp. 1-9. [10.1093/cid/ciz032]
File allegati a questo prodotto
File Dimensione Formato  
Bartoletti_extended-infusion_2019.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 345.29 kB
Formato Adobe PDF
345.29 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1281310
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 32
social impact